Article thumbnail

Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-Methyl-l,3-Benzodioxole Isolated from the Fruiting Body of Antrodia camphorate

By Hsiu-Man Lien, Hsiao-Wei Lin, Ying-Jan Wang, Li-Ching Chen, Ding-Yah Yang, Ya-Yun Lai and Yuan-Soon Ho


In this study, 4,7-dimethoxy-5-methyl-l,3-benzodioxole (SY-1) was isolated from three different sources of dried fruiting bodies of Antrodia camphorate (AC). AC is a medicinal mushroom that grows on the inner heartwood wall of Cinnamomum kanehirai Hay (Lauraceae), an endemic species that is used in Chinese medicine for its anti-tumor and immunomodulatory properties. In this study, we demonstrated that SY-1 profoundly decreased the proliferation of human colon cancer cells (COLO 205) through G0/G1 cell-cycle arrest (50–150 μM) and induction of apoptosis (>150 μM). Cell-cycle arrest induced by SY-1 was associated with a significant increase in levels of p53, p21/Cip1 and p27/Kip1, and a decrease in cyclins D1, D3 and A. In contrast, SY-1 treatment did not induce significant changes in G0/G1 phase cell-cycle regulatory proteins in normal human colonic epithelial cells (FHC). The cells were cultured in soft agar to evaluate anchorage-independent colony formation, and we found that the number of transformed colonies was significantly reduced in the SY-1-treated COLO 205 cells. These findings demonstrate for the first time that SY-1 inhibits human colon cancer cell proliferation through inhibition of cell growth and anchorage-independent colony formation in soft agar. However, the detailed mechanisms of these processes remain unclear and will require further investigation

Topics: Original Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A .F i g u e r e d o ,M .E .C o o m b e s ,a n dS .M u k h e r j e e ,“ A d j u -vant therapy for completely resected stage II colon cancer,” Cochrane Database of Systematic Reviews,
  2. (2003). a n ge ta l . ,“ I nv i t r oa n di nv i v o studiesoftheanticanceractionofterbinafineinhumancancer cell lines: G0/G1 p53-associated cell cycle arrest,”
  3. Akimitsu et al., “A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced
  4. (2007). Antiinflammatory benzenoids from Antrodia camphorata,”
  5. (2002). Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and
  6. (1995). C h i a n g ,W .D e - P e n g ,I .W .C h e r n g ,a n dU .C .C h u e n -Her, “A sesquiterpene lactone, phenyl and biphenyl compounds from Antrodia cinnamomea,”
  7. (2008). CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells,”
  8. (2008). Celecoxib upregulates multidrugresistanceproteinsincoloncancer: lack ofsynergy withstandardchemotherapy,”
  9. (1998). e e ,M .K .J a i n ,B .M .A r k o n a ce ta l . ,“ T h y - 1 ,a novel marker for angiogenesis upregulated by inflammatory cytokines,”
  10. (1998). F r a z i e r
  11. (2005). Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosis,”
  12. (2006). Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata,”
  13. (2003). Hasegawa et al.,“The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer,”
  14. (2008). Huang et al.,“Effects ofantrodia camphorataonviability,apoptosis,and[Ca 2+]iinPC3human prostatecancercells,”ChineseJournalofPhysiology,v ol.51,no
  15. (1980). Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis
  16. (2006). Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts,”
  17. (1996). Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells,”
  18. (1996). Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their10 Evidence-Based Complementary and Alternative Medicine association with apoptosis in human cancer cells,” Molecular Carcinogenesis,
  19. (2007). Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogennonresponsive breast cancer cells by Antrodia camphorata,”
  20. (2000). Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines,”
  21. (2008). Kr¨ a m e r ,S .K .K n a u e r ,D .Z i m m e r m a n n ,R
  22. (2005). Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways,” Food and Chemical Toxicology,
  23. (2006). Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signalsgenerated by phospholipaseD,”
  24. (1996). o w a n ,R .L .L u d w i g ,Y .H a u p t ,S .B a t e s ,X .L u ,M .O r e ne t al., “Specific lossofapoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant,”
  25. (1995). p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence,”
  26. (1997). p53, the cellular gatekeeper for growth and division,”
  27. (1996). p53: puzzle and paradigm,”
  28. (1984). Primary and long term epithelial cell cultures from human fetal normal colonic mucosa,”
  29. (2008). Principles and applications of gene therapy in colon cancer,”
  30. (1990). r e s s a c ,K .M .G a l v i n ,T .J .L i a n g ,K .J .I s s e l b a c h e r
  31. (2004). s e u ,H . - L .Y a n g ,Y . -
  32. (2005). S o n g ,S .L .H s u ,C .T .Y e h ,a n dG .C .Y e n ,“ M y c e l i af r o m Antrodia camphorata in Submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway,”
  33. (2008). Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors,”
  34. (2008). Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations,”
  35. (2008). Systemic therapy for colon cancer,”
  36. (2008). Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy,” Clinical and Experimental Metastasis,
  37. (2008). The adjuvant effects of Antrodia Camphorata extracts combined with antitumor agents on multidrug resistant human hepatoma cells,”
  38. (2008). Treatment of recurrent metastatic colon cancer in the age of modern adjuvant therapy,” Clinical Colorectal Cancer,v o l .7 ,n o .5 ,p p .
  39. (2003). Wang,“Transformationof non-cancerous humanbreast epithelial cell lineMCF10A by the tobacco-specific carcinogen